IP Library Granted Patent US 9,783,831
Granted Patent B2
US 9,783,831 · App. 15/436,611 · Granted Oct 10, 2017

Cyclodextrin glucanotransferase

Inventors: Elizabeth Jenkinson (Abingdon, GB); Preben Krabben (Didcot, GB); Amanda Harding (Abingdon, GB)
Assignee: GREEN BIOLOGICS LTD
C12P7/065C12N9/1074C12N15/74C12N15/75C12P7/16C12P7/28C12N2510/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,783,831
App. No.
15/436,611
Granted
Oct 10, 2017
Kind
B2
Abstract

The present invention relates to a novel cyclodextrin glucanotransferase (CGTase) enzyme which is obtainable from Clostridium saccharoperbutylacetonicum N1-4, N1-4(HMT) or N1-504. The invention further relates to nucleic acids encoding the enzyme, vectors and host cells, and uses of the CGTase.

Claims (39)

1. A method of producing a solvent comprising the steps:

(i) incubating a recombinant host cell comprising a heterologous nucleic acid molecule which is integrated into the host cell genome, wherein the nucleotide sequence of the heterologous nucleic acid molecule:

(a) encodes the amino acid sequence set forth in SEQ ID NO: 1 or 3;

(b) encodes a cyclodextrin glucanotransferase (CGTase) having at least 80% amino acid sequence identity with SEQ ID NO: 1 or 3;

(c) is set forth in SEQ ID NO: 2 or 4; or

(d) has at least 80% sequence identity with the nucleotide sequence set forth in SEQ ID NO: 2 or 4, and which encodes a CGTase,

wherein the host cell is neither Clostridium saccharoperbutylacetonicum N1-4 (HMT) nor Clostridium saccharoperbutylacetonicum N1-504, with a polysaccharide substrate;

wherein the host cell is capable of converting hydrolysed polysaccharide to an acid R—COOH, and wherein the host cell is further capable of converting the R—COOH into a solvent.

2. The method as claimed in claim 1 , wherein the solvent is selected from the group consisting of acetone, ethanol and/or butanol.

3. The method as claimed in claim 1 , wherein the host cell is a bacterial cell.

4. The method as claimed in claim 3 , wherein the bacterial cell is of the genus Clostridium or Bacillus.

5. The method as claimed in claim 3 , wherein the host cell is a biphasic bacteria.

6. The method as claimed in claim 4 , wherein the host cell is selected from the group consisting of C. acetobutylicum, C. aurantibutyricum, C. beijerinckii, C. thermocellum, C. thermobutyricum, C. pasteurianum, C. kluyveri, C. saccharobutylicum, C. thermosaccharolyticum, C. saccharolyticum, C. saccharoperbutylacetonicum, C. tyrobutyricum, C. butyricum, C. puniceum, C. diolis and C. roseum ; or the host cell is a Cluster I Clostridia.

7. A method of producing a solvent comprising the steps:

(i) incubating a host cell comprising a nucleic acid molecule which is integrated into the host cell genome, wherein the nucleotide sequence of the nucleic acid molecule:

(a) encodes the amino acid sequence set forth in SEQ ID NO: 1 or 3;

(b) encodes a cyclodextrin glucanotransferase (CGTase) having at least 80% amino acid sequence identity with SEQ ID NO: 1 or 3;

(c) is set forth in SEQ ID NO: 2 or 4; or

(d) has at least 80% sequence identity with the nucleotide sequence set forth in SEQ ID NO: 2 or 4, and which encodes a CGTase,

wherein the nucleic acid molecule is operably associated with a constitutive promoter, with a polysaccharide substrate;

wherein the host cell is capable of converting hydrolysed polysaccharide to an acid R—COOH, and wherein the host cell is further capable of converting the R—COOH into a solvent.

8. The method as claimed in claim 7 , wherein the solvent is selected from the group consisting of acetone, ethanol and/or butanol.

9. The method as claimed in claim 7 , wherein the host cell is a bacterial cell.

10. The method as claimed in claim 9 , wherein the bacterial cell is of the genus Clostridium or Bacillus.

11. The method as claimed in claim 9 , wherein the host cell is a biphasic bacteria.

12. The method as claimed in claim 10 , wherein the host cell is selected from the group consisting of C. acetobutylicum, C. aurantibutyricum, C. beijerinckii, C. thermocellum, C. thermobutyricum, C. pasteurianum, C. kluyveri, C. saccharobutylicum, C. thermosaccharolyticum, C. saccharolyticum, C. saccharoperbutylacetonicum, C. tyrobutyricum, C. butyricum, C. puniceum, C. diolis and C. roseum ; or the host cell is a Cluster I Clostridia.

13. A method of producing a solvent comprising the steps:

(i) incubating a host cell comprising two or more nucleic acid molecules which are integrated into the host cell genome, wherein the nucleotide sequence of the nucleic acid molecules:

(a) encodes the amino acid sequence set forth in SEQ ID NO: 1 or 3;

(b) encodes a cyclodextrin glucanotransferase (CGTase) having at least 80% amino acid sequence identity with SEQ ID NO: 1 or 3;

(c) is set forth in SEQ ID NO: 2 or 4; or

(d) has at least 80% sequence identity with the nucleotide sequence set forth in SEQ ID NO: 2 or 4, and which encodes a CGTase,

with a polysaccharide substrate;

wherein the host cell is capable of converting hydrolysed polysaccharide to an acid R—COOH, and wherein the host cell is further capable of converting the R—COOH into a solvent.

14. The method as claimed in claim 13 , wherein the solvent is selected from the group consisting of acetone, ethanol and/or butanol.

15. The method as claimed in claim 13 , wherein the host cell is a bacterial cell.

16. The method as claimed in claim 15 , wherein the bacterial cell is of the genus Clostridium or Bacillus.

17. The method as claimed in claim 15 , wherein the host cell is a biphasic bacteria.

18. The method as claimed in claim 16 , wherein the host cell is selected from the group consisting of C. acetobutylicum, C. aurantibutyricum, C. beijerinckii, C. thermocellum, C. thermobutyricum, C. pasteurianum, C. kluyveri, C. saccharobutylicum, C. thermosaccharolyticum, C. saccharolyticum, C. saccharoperbutylacetonicum, C. tyrobutyricum, C. butyricum, C. puniceum, C. diolis and C. roseum ; or the host cell is a Cluster I Clostridia.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE EXECUTION DATE FOR THE CONVEYING PARTY PREVIOUSLY RECORDED ON REEL 68257 FRAME 254. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 4, 2025
From: BIOCLEAVE LIMITED
To: BCL2020 LTD
Reel/Frame 070779/0847 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2024
From: BCL2020 LIMITED
To: NCIMB LIMITED
Reel/Frame 067950/0317 →
ASSET PURCHASE AGREEMENT Recorded Jul 9, 2024
From: BIOCLEAVE LIMITED
To: BCL2020 LTD
Reel/Frame 068257/0254 →
CHANGE OF NAME Recorded Jul 9, 2024
From: GREEN BIOLOGICS LIMITED
To: BIOCLEAVE LIMITED
Reel/Frame 068256/0143 →
RELEASE OF SECURITY INTEREST Recorded Nov 5, 2018
From: OBSIDIAN AGENCY SERVICES, INC.
To: GREEN BIOLOGICS LIMITED
Reel/Frame 047409/0037 →
NOTIFICATION OF CHANGE OF ADDRESS Recorded May 23, 2018
From: GREEN BIOLOGICS LIMITED
To: GREEN BIOLOGICS LIMITED
Reel/Frame 047304/0556 →
SECURITY INTEREST Recorded Aug 24, 2017
From: GREEN BIOLOGICS LIMITED
To: OBSIDIAN AGENCY SERVICES, INC.
Reel/Frame 043392/0406 →
Priority Claims (2)
GB 1302030.0 · Feb 5, 2013 · national
GB 1303595.1 · Feb 28, 2013 · national
Continuity (3)
Continuation 15293189 · Oct 13, 2016
Continuation 14765795
Related Publication 20170166932A1 · Jun 15, 2017